Beurs gesloten -
Nasdaq
22:30:00 21-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3,38
USD
|
+0,59%
|
|
+1,20%
|
+56,48%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
139,4
|
85,42
|
68,53
|
50,11
|
81,82
|
-
|
-
|
Bedrijfswaarde
1 |
139,4
|
85,42
|
68,53
|
50,11
|
81,82
|
81,82
|
81,82
|
K/w-verhouding
|
-1,53
x
|
-2,65
x
|
-1,79
x
|
-1,04
x
|
-2,05
x
|
-2,62
x
|
-6,26
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3,27
x
|
1,8
x
|
1,39
x
|
2,02
x
|
2,97
x
|
2,28
x
|
1,27
x
|
Bedrijfswaarde/omzet
|
3,27
x
|
1,8
x
|
1,39
x
|
2,02
x
|
2,97
x
|
2,28
x
|
1,27
x
|
Bedrijfswaarde/EBITDA
|
-14,3
x
|
-4,43
x
|
-
|
-3,43
x
|
-4,73
x
|
-4,81
x
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
10.226
|
13.559
|
16.124
|
23.198
|
24.350
|
-
|
-
|
Referentieprijs
2 |
13,63
|
6,300
|
4,250
|
2,160
|
3,380
|
3,380
|
3,380
|
Datum van publicatie
|
1/03/21
|
3/03/22
|
22/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
42,9
|
42,68
|
47,39
|
49,19
|
24,74
|
27,55
|
35,9
|
64,2
|
EBITDA
1 |
-
|
-9,735
|
-19,3
|
-
|
-14,62
|
-17,3
|
-17
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-13,6
|
-23,03
|
-31,74
|
-30,53
|
-27,45
|
-23,55
|
-3
|
Operationele Marge
|
-
|
-31,86%
|
-48,6%
|
-64,53%
|
-123,36%
|
-99,64%
|
-65,6%
|
-4,67%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-21,8
|
-24,78
|
-32,86
|
-41,22
|
-40,25
|
-32,25
|
-15,3
|
Nettowinst (verlies)
1 |
-11,94
|
-25,34
|
-24,83
|
-32,9
|
-37,66
|
-40,25
|
-32,25
|
-15,3
|
Nettomarge
|
-27,83%
|
-59,36%
|
-52,4%
|
-66,88%
|
-152,18%
|
-146,1%
|
-89,83%
|
-23,83%
|
WPA
2 |
-1,320
|
-8,880
|
-2,380
|
-2,380
|
-2,074
|
-1,645
|
-1,290
|
-0,5400
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/07/20
|
1/03/21
|
3/03/22
|
22/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
11,48
|
10,86
|
11,5
|
12,64
|
12,39
|
12,66
|
13,05
|
10,3
|
6,127
|
5,875
|
6,694
|
6,65
|
6,95
|
7,25
|
EBITDA
1 |
-6,044
|
-6,829
|
-5,993
|
-7,248
|
-6,86
|
-
|
-
|
-
|
-6,418
|
-4,505
|
-3,633
|
-4,7
|
-4,4
|
-4,5
|
Bedrijfsresultaat (EBIT)
1 |
-6,976
|
-7,762
|
-6,922
|
-8,182
|
-7,793
|
-8,843
|
-6,418
|
-9,085
|
-7,371
|
-8,507
|
-8,479
|
-6,45
|
-6,1
|
-6,4
|
Operationele Marge
|
-60,74%
|
-71,47%
|
-60,22%
|
-64,74%
|
-62,9%
|
-69,82%
|
-49,18%
|
-88,24%
|
-120,3%
|
-144,8%
|
-126,67%
|
-96,99%
|
-87,77%
|
-88,28%
|
Resultaat voor belastingen (EBT)
1 |
-8,304
|
-9,052
|
-8,137
|
-9,386
|
-9,898
|
-5,442
|
-7,962
|
-10,61
|
-8,507
|
-15,23
|
-17,99
|
-8,65
|
-8,25
|
-5,35
|
Nettowinst (verlies)
1 |
-8,316
|
-9,064
|
-8,149
|
-9,398
|
-9,91
|
-5,44
|
-7,974
|
-10,62
|
-9,747
|
-9,316
|
-17,99
|
-8,65
|
-8,25
|
-5,35
|
Nettomarge
|
-72,41%
|
-83,45%
|
-70,89%
|
-74,36%
|
-79,99%
|
-42,95%
|
-61,1%
|
-103,16%
|
-159,08%
|
-158,57%
|
-268,81%
|
-130,08%
|
-118,71%
|
-73,79%
|
WPA
2 |
-0,8100
|
-0,8200
|
-0,6000
|
-0,6900
|
-0,7300
|
-0,3800
|
-0,4900
|
-0,6500
|
-0,5000
|
-0,4016
|
-0,7500
|
-0,3600
|
-0,3300
|
-0,2200
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
9/11/21
|
3/03/22
|
9/05/22
|
11/08/22
|
14/11/22
|
22/03/23
|
10/05/23
|
14/08/23
|
13/11/23
|
7/03/24
|
9/05/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
0,64
|
0,37
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
1,5%
|
0,78%
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/07/20
|
1/03/21
|
3/03/22
|
22/03/23
|
7/03/24
|
-
|
-
|
-
|
Laatste slotkoers
3,36
USD Gemiddelde koersdoel
5
USD Spread / Gemiddelde doel +48,80% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +56,48% | 81,82 mln. | | -3,15% | 89,69 mld. | | +2,50% | 41,34 mld. | | -12,01% | 33,72 mld. | | +62,74% | 26,11 mld. | | -19,79% | 14,63 mld. | | -8,58% | 12,84 mld. | | -12,34% | 11,66 mld. | | -43,92% | 11,52 mld. | | +4,27% | 8,92 mld. |
Biofarmaceutica
|